Literature DB >> 21259400

Investigation of pituitary adenylate cyclase activating polypeptide in human gynecological and other biological fluids by using MALDI TOF mass spectrometry.

R Brubel1, D Reglodi, E Jambor, M Koppan, A Varnagy, Zs Biro, P Kiss, V Gaal, A Matkovits, J Farkas, A Lubics, J Bodis, Cs Bay, B Veszpremi, A Tamas, J Nemeth, Laszlo Mark.   

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) is a multifunctional and pleiotropic neuropeptide. PACAP has diverse effects in the endocrine system, among others, it plays important roles in oogenesis, implantation and development of the nervous system. However, it is not known whether PACAP is present in the fluids of the human reproductive organs. The aim of the present study was to determine, by means of mass spectrometry and radioimmunoassay, whether PACAP is present in human amniotic fluid, ovarian follicular fluid and cervico-vaginal fluid. Samples were obtained from healthy adult volunteers. Our MALDI TOF and MALDI TOF/TOF spectrometry results show that PACAP38 is present in all of the follicular fluid samples, and PACAP-like immunoreactivity was also measured by radioimmunoassay. However, we did not find the characteristic peak representing the unmodified 38 amino acid form of the peptide in normal cervico-vaginal smear and amniotic fluid samples. Furthermore, we analyzed other body fluids for comparison, such as human nasal fluid, saliva and aqueous humor. PACAP was not found in these latter samples. In summary, the present study provides evidence for the presence of PACAP in human follicular fluid, suggesting a role in oocyte function, but determination of the exact physiological significance awaits further investigation.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21259400     DOI: 10.1002/jms.1884

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  10 in total

1.  PACAP immunoreactivity in human malignant tumor samples and cardiac diseases.

Authors:  Z Szanto; Zs Sarszegi; D Reglodi; J Nemeth; K Szabadfi; P Kiss; A Varga; E Banki; K Csanaky; B Gaszner; O Pinter; Zs Szalai; A Tamas
Journal:  J Mol Neurosci       Date:  2012-05-31       Impact factor: 3.444

2.  Changes in PACAP immunoreactivity in human milk and presence of PAC1 receptor in mammary gland during lactation.

Authors:  Katalin Csanaky; Eszter Banki; Krisztina Szabadfi; Dora Reglodi; Ibolya Tarcai; Levente Czegledi; Zsuzsanna Helyes; Tibor Ertl; Judit Gyarmati; Zalan Szanto; Istvan Zapf; Erika Sipos; Seiji Shioda; Andrea Tamas
Journal:  J Mol Neurosci       Date:  2012-04-27       Impact factor: 3.444

3.  Effects of pituitary adenylate cyclase activating polypeptide on human sperm motility.

Authors:  R Brubel; P Kiss; A Vincze; A Varga; A Varnagy; J Bodis; L Mark; E Jambor; G Maasz; H Hashimoto; Zs Helyes; G Toth; A Tamas; M Koppan; D Reglodi
Journal:  J Mol Neurosci       Date:  2012-05-26       Impact factor: 3.444

4.  Correlation between oocyte number and follicular fluid concentration of pituitary adenylate cyclase-activating polypeptide (PACAP) in women after superovulation treatment.

Authors:  M Koppan; A Varnagy; D Reglodi; R Brubel; J Nemeth; A Tamas; L Mark; J Bodis
Journal:  J Mol Neurosci       Date:  2012-03-14       Impact factor: 3.444

5.  Distribution of PACAP and PAC1 Receptor in the Human Eye.

Authors:  Evelin Patko; Edina Szabo; Denes Toth; Tamas Tornoczky; Inez Bosnyak; Alexandra Vaczy; Tamas Atlasz; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2022-03-07       Impact factor: 3.444

6.  Influence of terminal differentiation and PACAP on the cytokine, chemokine, and growth factor secretion of mammary epithelial cells.

Authors:  Katalin Csanaky; Wolfgang Doppler; Andrea Tamas; Krisztina Kovacs; Gabor Toth; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2013-12-10       Impact factor: 3.444

7.  The synovial fluid neuropeptide PACAP may act as a protective factor during disease progression of primary knee osteoarthritis and is increased following hyaluronic acid injection.

Authors:  Zheng-Ping Sun; Shao-Peng Wu; Can-De Liang; Chuan-Xi Zhao; Bing-Yin Sun
Journal:  Innate Immun       Date:  2019-04-01       Impact factor: 2.680

Review 8.  The Neuroprotective and Biomarker Potential of PACAP in Human Traumatic Brain Injury.

Authors:  Denes Toth; Andrea Tamas; Dora Reglodi
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

Review 9.  Female reproductive functions of the neuropeptide PACAP.

Authors:  Miklos Koppan; Zsuzsanna Nagy; Inez Bosnyak; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

10.  Role of PACAP in Female Fertility and Reproduction at Gonadal Level - Recent Advances.

Authors:  Dora Reglodi; Andrea Tamas; Miklos Koppan; Donat Szogyi; Laura Welke
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-11       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.